Cargando…
Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
BACKGROUND: The accumulation of neurotoxic amyloid-beta (Aβ) in the brain is a characteristic of Alzheimer's disease (AD), at the same time, it is possible alterations of liver function could affect brain Aβ levels through changes in blood Aβ concentration. Over the last decade, a number of rep...
Autores principales: | Wen, Jinhua, Zhao, Menghua, Sun, Wenxiong, Cheng, Xiaohua, Yu, Luyi, Cao, Duanwen, Li, Pu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439072/ https://www.ncbi.nlm.nih.gov/pubmed/34521342 http://dx.doi.org/10.1186/s12868-021-00658-9 |
Ejemplares similares
-
Publisher Correction to: Uptake of Aβ by OATPs might be a new pathophysiological mechanism of Alzheimer disease
por: Wen, Jinhua, et al.
Publicado: (2021) -
OATP1B1 Plays an Important Role in the Transport and Treatment Efficacy of Sorafenib in Hepatocellular Carcinoma
por: Wen, Jinhua, et al.
Publicado: (2021) -
Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
por: Nies, Anne T, et al.
Publicado: (2013) -
Ginsenoside Rb1 and Rd Remarkably Inhibited the Hepatic Uptake of Ophiopogonin D in Shenmai Injection Mediated by OATPs/oatps
por: Liu, Xiaopei, et al.
Publicado: (2018) -
Berberine Promotes OATP1B1 Expression and Rosuvastatin Uptake by Inducing Nuclear Translocation of FXR and LXRα
por: Liu, Mingyi, et al.
Publicado: (2020)